Nanshan Zhong

72.8k total citations · 10 hit papers
551 papers, 18.1k citations indexed

About

Nanshan Zhong is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Nanshan Zhong has authored 551 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 316 papers in Pulmonary and Respiratory Medicine, 164 papers in Physiology and 91 papers in Infectious Diseases. Recurrent topics in Nanshan Zhong's work include Asthma and respiratory diseases (136 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (123 papers) and Respiratory and Cough-Related Research (85 papers). Nanshan Zhong is often cited by papers focused on Asthma and respiratory diseases (136 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (123 papers) and Respiratory and Cough-Related Research (85 papers). Nanshan Zhong collaborates with scholars based in China, United States and United Kingdom. Nanshan Zhong's co-authors include Yimin Li, Wei‐jie Guan, Haibo Zhang, Arthur S. Slutsky, Josef Penninger, Kian Fan Chung, Xueyan Zheng, Jinping Zheng, Pixin Ran and Zifeng Yang and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Nanshan Zhong

532 papers receiving 17.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

2020 1.9k citations Nanshan Zhong et al. profile →
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

2020 829 citations Nanshan Zhong, Jianxing He et al. profile →
Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action

2016 708 citations Nanshan Zhong et al. profile →
Prevalence of Chronic Obstructive Pulmonary Disease in China

2007 558 citations Nanshan Zhong, Chen Wang et al. American Journal of Respiratory and Critical Care Medicine profile →
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease

2003 558 citations Nanshan Zhong et al. European Respiratory Journal profile →
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

2020 529 citations Nanshan Zhong, Shiyue Li et al. European Respiratory Journal profile →
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

2020 495 citations Chufang Li, Jin Zhao et al. profile →
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

2018 366 citations Nanshan Zhong et al. profile →
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

2020 338 citations Zifeng Yang, Nanshan Zhong et al. profile →
As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

2018 303 citations Nanshan Zhong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanshan Zhong China	58	7.0k	4.6k	4.0k	2.4k	1.9k	551	18.1k
David S.C. Hui Hong Kong	84	6.5k 0.9×	11.1k 2.4×	3.7k 0.9×	3.0k 1.2×	6.6k 3.4×	420	27.9k
Gerard J. Criner United States	71	15.8k 2.3×	1.1k 0.2×	5.6k 1.4×	1.3k 0.6×	1.4k 0.8×	511	20.5k
Samy Suissa Canada	92	9.6k 1.4×	1.2k 0.3×	6.7k 1.7×	2.8k 1.1×	3.9k 2.0×	491	33.5k
Tobias Welte Germany	89	13.5k 1.9×	5.7k 1.2×	3.3k 0.8×	3.5k 1.4×	10.3k 5.4×	957	35.3k
Yaseen M. Arabi Saudi Arabia	65	6.5k 0.9×	3.0k 0.6×	1.5k 0.4×	1.1k 0.5×	5.5k 2.8×	379	20.1k
Christian Torp‐Pedersen Denmark	107	4.3k 0.6×	1.5k 0.3×	3.0k 0.8×	3.3k 1.4×	5.1k 2.7×	1.3k	52.4k
Carolyn S. Calfee United States	62	8.4k 1.2×	1.7k 0.4×	848 0.2×	2.4k 1.0×	4.8k 2.5×	218	15.5k
Harry van Goor Netherlands	73	2.8k 0.4×	4.8k 1.0×	2.2k 0.5×	5.3k 2.2×	1.9k 1.0×	626	27.0k
Antonio Anzueto United States	61	20.6k 2.9×	2.4k 0.5×	7.1k 1.8×	1.6k 0.7×	12.3k 6.4×	297	34.8k
Mario Plebani Italy	86	3.3k 0.5×	6.1k 1.3×	9.3k 2.3×	4.6k 1.9×	4.7k 2.4×	1.2k	38.9k

Countries citing papers authored by Nanshan Zhong

Since Specialization

Citations

This map shows the geographic impact of Nanshan Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanshan Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanshan Zhong more than expected).

Fields of papers citing papers by Nanshan Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanshan Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanshan Zhong. The network helps show where Nanshan Zhong may publish in the future.

Co-authorship network of co-authors of Nanshan Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Nanshan Zhong. A scholar is included among the top collaborators of Nanshan Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanshan Zhong. Nanshan Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fang, Zhangfu, Zhe Chen, Yang Peng, et al.. (2024). Fine particulate matter contributes to COPD-like pathophysiology: experimental evidence from rats exposed to diesel exhaust particles. Respiratory Research. 25(1). 14–14. 15 indexed citations

Zhou, Chengzhi, Haiyi Deng, Yi‐Lin Yang, et al.. (2024). Cancer therapy-related interstitial lung disease. Chinese Medical Journal. 138(3). 264–277. 3 indexed citations

Zhang, Weihong, Bin Xiao, Banglao Xu, et al.. (2024). Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk. Journal of Virology. 98(12). e0128524–e0128524. 1 indexed citations

Cui, Tingting, Xiaoling Su, Jing Sun, et al.. (2023). Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting. EBioMedicine. 99. 104903–104903. 4 indexed citations

Liu, Wei, Chufang Li, Jintao Li, et al.. (2023). Effects of Shiwei Longdanhua formula on LPS induced airway mucus hypersecretion, cough hypersensitivity, oxidative stress and pulmonary inflammation. Biomedicine & Pharmacotherapy. 163. 114793–114793. 9 indexed citations

Lai, Kefang, et al.. (2022). Clinical characteristics in adult patients with somatic cough syndrome. Therapeutic Advances in Respiratory Disease. 16. 2673672321–2673672321. 5 indexed citations

Sun, Weimin, et al.. (2021). SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses. Healthcare. 9(9). 1132–1132. 8 indexed citations

Zheng, Qiuyu, Wenju Lu, Yan Han, et al.. (2021). Established pulmonary hypertension in rats was reversed by a combination of a HIF‐2α antagonist and a p53 agonist. British Journal of Pharmacology. 179(5). 1065–1081. 20 indexed citations

Zhong, Shan, Li‐Ping Bai, Lee‐Fong Yau, et al.. (2021). Cough Inhibition Activity of Schisandra chinensis in Guinea Pigs. Journal of Medicinal Food. 24(4). 348–357. 4 indexed citations

10.

Islam, Md. Mahmudul, Yaoju Tan, H. M. Adnan Hameed, et al.. (2020). Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. Microbial Drug Resistance. 26(7). 766–775. 12 indexed citations

11.

Li, Chenglong, Yumin Zhou, Sha Liu, et al.. (2019). Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study. ERJ Open Research. 5(1). 175–2018. 10 indexed citations

12.

Yang, Lei, Xiaorong Yang, Weidong Ji, et al.. (2014). Effects of a Functional Variant c.353T>C in Snai1 on Risk of Two Contextual Diseases. Chronic Obstructive Pulmonary Disease and Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 189(2). 139–148. 33 indexed citations

13.

Yang, Zifeng, Yutao Wang, Zhaoguang Zheng, et al.. (2013). Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro. International Journal of Molecular Medicine. 31(4). 867–873. 77 indexed citations

14.

Deng, Fei, et al.. (2012). Pulmonary Circulation. Respirology. 17(S2). 105–105. 4 indexed citations

15.

Lai, Kefang, et al.. (2011). Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis. European Respiratory Journal. 38(Suppl 55). p483–p483. 1 indexed citations

16.

Zheng, Zeguang, et al.. (2010). Application of speech recognition technology in the automatic recognition of cough sounds. 16(6). 564–566. 2 indexed citations

17.

Li, Shiyue, Yi Gao, Jingping Zheng, Jianxing He, & Nanshan Zhong. (2009). Correlation between quantitative CT findings and pulmonary function tests in pulmonary alveolar proteinosis. 15(5). 340–343. 1 indexed citations

18.

Zhong, Nanshan, Chen Wang, Wan-zhen Yao, et al.. (2007). Prevalence of Chronic Obstructive Pulmonary Disease in China. American Journal of Respiratory and Critical Care Medicine. 176(8). 753–760. 558 indexed citations breakdown →

19.

Zhong, Nanshan. (2007). Surveillance of antimicrobial resistance in gram-negative bacilli isolated from lower respiratory tract of patients in Respiratory Intensive Care Unit for 5 consecutive years. 1 indexed citations

20.

Zhong, Nanshan. (2006). Pathological features of airway inflammation in eosinophilic bronchitis. Zhongguo bingli shengli zazhi. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact